Medtronic Inc. (NYSE: MDT) says it's resolved U.S. Food and Drug Administration warning letter issues at two manufacturing facilities -- clearing the way for new product launches.
Medtronic Inc. (NYSE: MDT) has launched in Europe a line of implantable cardioverter defibrillators that are designed to reduce unnecessary shocks. The company’s Protecta ICDs and cardiac resynchronization therapy devices feature six algorithms to reduce inappropriate shocks, which can affect 20 percent of patients who have implantable defibrillators, according to a statement from the company. […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.